デフォルト表紙
市場調査レポート
商品コード
1608879

サル痘診断市場:検査の種類別、手法別、コンポーネント別、エンドユーザー別、地域別

Monkeypox Diagnosis Market, By Test Type (Polymerase Chain Reaction Tests, Serological Tests, Antigen Detection Tests, and Viral Culture Tests), By Mode, By Component, By End User, By Geography


出版日
ページ情報
英文 145 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
サル痘診断市場:検査の種類別、手法別、コンポーネント別、エンドユーザー別、地域別
出版日: 2024年11月20日
発行: Coherent Market Insights
ページ情報: 英文 145 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のサル痘 (Mpox) 診断市場は、2024年には19億7,000万米ドルと推定され、2031年には26億2,000万米ドルに達すると予測され、2024年から2031年までのCAGRは4.2%です。

レポート範囲 レポート詳細
基準年 2023 2024年の市場規模 19億7,000万米ドル
実績データ 2019年~2023年 予測期間 2024年から2031年
予測期間2024年から2031年 CAGR: 4.20% 2031年の価値予測 26億2,000万米ドル
図.サル痘 (Mpox) 診断市場シェア (%)、2024年、地域別
Monkeypox Diagnosis Market-IMG1

2022年に世界で発生したサル痘ウイルス (MPXV) は、この疾患の迅速な診断の必要性を浮き彫りにしました。サル痘は、サル痘ウイルスの感染によって引き起こされるまれなウイルス性人獣共通感染症です。臨床的には発熱、発疹、リンパ節の腫脹を呈し、通常は自己軽快します。しかし、重症化することもあります。感染者の隔離や接触者の追跡を通じてヒトからヒトへの感染を制限するためには、迅速な診断が極めて重要です。

市場力学

世界のサル痘 (Mpox) 診断市場は、世界的にサル痘患者が発生し続けていることに牽引されています。通常サル痘が発見されない新しい地域や国にサル痘が持続的に広がっているため、検査ニーズが高まっています。他のオルトポックスウイルスとともにサル痘を検出できる多重ポリメラーゼ連鎖反応検査のような新しい診断技術の導入が普及を後押ししています。しかし、世界の一部の地域では、一般市民や医療従事者の間で疾患に対する認識が低いため、正確な診断が課題となっています。迅速なポイントオブケア (PoC) 検査開発のための研究開発は、長期的には市場参入企業に有利な機会を提供します。

当研究の主な特徴

当レポートでは、世界のサル痘 (Mpox) 診断市場を詳細に分析し、2023年を基準年とした予測期間 (2024-2031年) の市場規模 (10億米ドル) および複合年間成長率 (CAGR、%) を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

世界のサル痘 (Mpox) 診断市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。

当研究の対象となる主要企業は次の通りです:Aegis Sciences Corporation、Laboratory Corporation of America Holdings、Quest Diagnostics Incorporated、Sonic Healthcare Limited、QIAGEN、Mayo Clinic Laboratories、Chembio Diagnostics, Inc、Sonora Quest Laboratories, Thermo Fisher Scientific, BD (Becton, Dickinson and Company) , CerTest Biotech, GenMark Diagnostics, Inc, Roche Diagnostics, Abbott Laboratories, Hologic, Inc, Siemens Healthineers, PerkinElmer, Inc, Bio-Rad Laboratories, Inc, Agilent Technologies, Inc。

当レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、種類の更新、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界のサル痘 (Mpox) 診断市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界のサル痘 (Mpox) 診断市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 分析目的と前提条件

  • 分析目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学・規制・動向の分析

  • 市場力学
  • 影響分析
  • 主な動向
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • Porterの分析
  • 企業合併・買収 (M&A) のシナリオ
  • 業界動向

第4章 世界のサル痘 (Mpox) 診断市場:検査の種類別、2019~2031年 (10億米ドル)

  • ポリメラーゼ連鎖反応 (PCR) 検査
  • 血清学的検査
  • 抗原検出検査
  • ウイルス培養検査

第5章 世界のサル痘 (Mpox) 診断市場:手法別、2019~2031年 (10億米ドル)

  • 臨床検査
  • ポイントオブケア検査

第6章 世界のサル痘 (Mpox) 診断市場:コンポーネント別、2019~2031年 (10億米ドル)

  • ハードウェア
  • ソフトウェア

第7章 世界のサル痘 (Mpox) 診断市場:エンドユーザー別、2019~2031年 (10億米ドル)

  • 病院と診療所
  • 診断検査室
  • その他

第8章 世界のサル痘 (Mpox) 診断市場:地域別、2019~2031年 (10億米ドル)

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第9章 競合情勢

  • Aegis Sciences Corporation
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • QIAGEN
  • Mayo Clinic Laboratories
  • Chembio Diagnostics, Inc.
  • Sonora Quest Laboratories
  • Thermo Fisher Scientific
  • BD (Becton, Dickinson and Company)
  • CerTest Biotech
  • GenMark Diagnostics, Inc.
  • Roche Diagnostics
  • Abbott Laboratories
  • Hologic, Inc.
  • Siemens Healthineers
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Meridian Bioscience, Inc.

第10章 アナリストの提言

  • 「運命の輪」
  • アナリストの見解
  • Coherent Opportunity Map (COM)

第11章 参考文献と調査手法

  • 参考文献
  • 分析手法
  • Coherent Market Insightsについて
目次
Product Code: CMI7495

Global monkeypox (Mpox) diagnosis market is estimated to be valued at USD 1.97 Bn in 2024 and is expected to reach USD 2.62 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 1.97 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 4.20% 2031 Value Projection: 2.62 Bn
Figure. Monkeypox (Mpox) Diagnosis Market Share (%), By Region 2024
Monkeypox  Diagnosis Market - IMG1

Global monkeypox virus (MPXV) outbreak in 2022 highlighted the need for prompt diagnosis of the disease. Monkeypox is a rare viral zoonotic disease that is caused by infection with the Monkeypox virus. The disease presents clinically with fever, rash, and swollen lymph nodes and is usually self-limiting. However, severe cases can occur. Timely diagnosis is crucial to limit human-to-human transmission through isolation of infected patients and contact tracing.

Market Dynamics

Global monkeypox (Mpox) diagnosis market is driven by the ongoing outbreak of monkeypox cases globally. The sustained spread of monkeypox to new regions and countries where it is not usually found has prompted greater testing needs. Introduction of novel diagnostics technologies such as multiplex polymerase chain reaction tests that can detect monkeypox alongside other orthopox viruses is boosting adoption. However, low disease awareness among the public and healthcare workers in some parts of the world poses a challenge for accurate diagnosis. Increasing research activities for the development of rapid point-of-care tests provide lucrative opportunities for market players in the long run.

Key Features of the Study

This report provides in-depth analysis of the global monkeypox (Mpox) diagnosis market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global monkeypox (Mpox) diagnosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Aegis Sciences Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, QIAGEN, Mayo Clinic Laboratories, Chembio Diagnostics, Inc., Sonora Quest Laboratories, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), CerTest Biotech, GenMark Diagnostics, Inc., Roche Diagnostics, Abbott Laboratories, Hologic, Inc., Siemens Healthineers, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and Meridian Bioscience, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global monkeypox (Mpox) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monkeypox (Mpox) diagnosis market

Market Segmentation

  • By Test Type Insights (Revenue, USD Bn, 2019 - 2031)
    • Polymerase Chain Reaction (PCR) Tests
    • Serological Tests
    • Antigen Detection Tests
    • Viral Culture Tests
  • By Mode Insights (Revenue, USD Bn, 2019 - 2031)
    • Laboratory Testing
    • Point of Care Testing
  • By Component Insights (Revenue, USD Bn, 2019 - 2031)
    • Hardware
    • Software
  • By End User Insights (Revenue, USD Bn, 2019 - 2031)
    • Hospitals and Clinics
    • Diagnostic Laboratories
    • Others
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Aegis Sciences Corporation
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Sonic Healthcare Limited
    • QIAGEN
    • Mayo Clinic Laboratories
    • Chembio Diagnostics, Inc.
    • Sonora Quest Laboratories
    • Thermo Fisher Scientific
    • BD (Becton, Dickinson and Company)
    • CerTest Biotech
    • GenMark Diagnostics, Inc.
    • Roche Diagnostics
    • Abbott Laboratories
    • Hologic, Inc.
    • Siemens Healthineers
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Meridian Bioscience, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Monkeypox (Mpox) Diagnosis Market, By Test Type
    • Global Monkeypox (Mpox) Diagnosis Market, By Mode
    • Global Monkeypox (Mpox) Diagnosis Market, By Component
    • Global Monkeypox (Mpox) Diagnosis Market, By End User
    • Global Monkeypox (Mpox) Diagnosis Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Monkeypox (Mpox) Diagnosis Market, By Test Type, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Polymerase Chain Reaction (PCR) Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Serological Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Antigen Detection Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Viral Culture Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Monkeypox (Mpox) Diagnosis Market, By Mode, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Laboratory Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Point of Care Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Monkeypox (Mpox) Diagnosis Market, By Component, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hardware
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Monkeypox (Mpox) Diagnosis Market, By End User, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Monkeypox (Mpox) Diagnosis Market, By Region, 2019 - 2031, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Test Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Mode, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Component, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Test Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Mode, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Component, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Test Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Mode, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Component, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Test Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Mode, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Component, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Test Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Mode, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Component, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Test Type, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Mode, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Component, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Aegis Sciences Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Laboratory Corporation of America Holdings
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sonic Healthcare Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mayo Clinic Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Chembio Diagnostics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sonora Quest Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD (Becton, Dickinson and Company)
  • CerTest Biotech
  • GenMark Diagnostics, Inc.
  • Roche Diagnostics
  • Abbott Laboratories
  • Hologic, Inc.
  • Siemens Healthineers
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Meridian Bioscience, Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us